'We're Confident Arrowhead's ARC-520 Is Active Drug For HBV,' Piper Jaffray Says
September 25, 2015 at 12:04 PM EDT
Shares of Arrowhead Research Corp (NASDAQ: ARWR) lost more than 50 percent from a year ago. Edward Tenthoff of Piper Jaffray left ...